© 2025 MJH Life Sciences™ , Patient Care Online – Primary Care News and Clinical Resources. All rights reserved.
Grace Halsey
Articles
Intranasal Flu Vaccine Coadministered with High-Dose Shot More Effective in Older Adults than Shot Alone
July 15, 2024
The investigational live intranasal vaccine was safe and well-tolerated when given concomitantly with Fluzone HD and the combination outperformed the latter given by itself.
GRAIL Multicancer Early Detection Test Registrational Trials Make Good Progress, Company Says
July 15, 2024
The PATHFINDER 2 and HMS-Galleri trials are proceeding as planned with more than 175 000 participants from diverse backgrounds enrolled across both.
Novel Combination Treatment is Potent Driver of Beta Cell Proliferation in Type 1 Diabetes Model
July 12, 2024
In the mouse model of type 1 diabetes, a combined harmine/exendin-4 therapy resulted in an up to 7-fold increase in β cell numbers over 3 months, reported investigators.
Combined SGLT2i and GLP-1 RA Therapy Provides Complementary Cardiorenal Protection, According to Comprehensive Meta-Analysis
July 12, 2024
Findings from the large meta-analysis provide strong support for use of both classes to reduce CV and renal disease in adults with type 2 diabetes.
Roflumilast Cream 0.15% Approved for Treatment of Atopic Dermatitis in People Aged 6 Years and Older
July 11, 2024
The steroid-free cream was developed for long-term use and has been proven safe in an open-label extension study following successful phase 3 trials.
FDA Issues CRL to Novo Nordisk for Once-Weekly Insulin Icodec
July 11, 2024
The agency is concerned about manufacturing processes involved in production and about the proposed indication for adults with type 1 diabetes.
In the Old and Very Old, Statins Appear Safe for Primary CVD Prevention, New Analysis Finds
July 10, 2024
Continuous statin use among adults aged 75 years and older resulted in a mean relative risk reduction in CVD of 28% without heightened safety concerns, a new study found.
Prenatal RSV Vaccine Not Associated with Preterm Birth, According to First Real-World Data
July 09, 2024
Data from a study performed during the first season the shot was available expand on clinical trial evidence and support the safety of RSVpreF, authors wrote.
Weight Loss with Tirzepatide Significantly Greater than with Semaglutide: New Data
July 08, 2024
Tirzepatide-treated participants were 3 times more likely than those treated with semaglutide to reach weight loss of 15% or greater, the head-to-head study found.
Exercise Plus GLP-1 RA May Preserve BMD During Weight Loss, Study Finds
July 03, 2024
The preserved bone mass observed in participants taking liraglutide and exercising was seen despite weight reduction levels similar to outcomes with semaglutide and tirzepatide.